|
業務類別
|
Biotechnology |
|
業務概覽
|
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States. |
| 公司地址
| 26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849 |
| 電話號碼
| +972 37658585 |
| 傳真號碼
| +972 37658555 |
| 公司網頁
| https://www.cgen.com |
| 員工數量
| 75 |
| Dr. Sharon Kredo-Russo, PhD |
Senior Vice President, Research and Discovery |
-- |
02/03/2026 |
| Dr. Michelle Mahler, M.D. |
Chief Medical Officer |
美元 382.40K |
02/03/2026 |
| Dr. Eran Ophir, PhD |
Director, President and Chief Executive Officer |
美元 295.06K |
02/03/2026 |
| Dr. Zurit Levine,PhD |
Senior Vice President, Business Development |
美元 208.58K |
02/03/2026 |
| Mr. David Silberman |
Chief Financial Officer |
-- |
02/03/2026 |
| Dr. Pierre Ferre, Pd.D |
Chief Operating Officer |
美元 277.24K |
02/03/2026 |
|
|
| Mr. Sanford S. Zweifach |
Independent Director |
02/03/2026 |
| Dr. Mathias Hukkelhoven, PhD |
Independent Director |
02/03/2026 |
| Dr. Eran Ophir, PhD |
Director, President and Chief Executive Officer |
02/03/2026 |
| Mr. Eran Perry |
Independent Director |
02/03/2026 |
| Dr. Kinneret Livnat Savitzky, PhD |
Independent Director |
02/03/2026 |
| Mr. Gilead Halevy |
Lead Independent Director |
02/03/2026 |
| Dr. Anat Cohen-Dayag, PhD |
Executive Chairman of the Board |
02/03/2026 |
| Dr. Michele A. M. Holcomb, PhD |
Independent Director |
02/03/2026 |
|
|
|
|
